Cargando…
Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
In rare cases of differentiated thyroid carcinoma (DTC), radioiodine treatment is no longer effective due to cell dedifferentiation. Targeting somatostatin receptors in DTC cells by radiolabelled somatostatin analogues could provide an alternative therapy option. The aim of this study was to evaluat...
Autores principales: | Czepczyński, Rafał, Matysiak-Grześ, Magdalena, Gryczyńska, Maria, Bączyk, Maciej, Wyszomirska, Anna, Stajgis, Marek, Ruchała, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Basel
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359293/ https://www.ncbi.nlm.nih.gov/pubmed/25403743 http://dx.doi.org/10.1007/s00005-014-0318-6 |
Ejemplares similares
-
Lack of TSH stimulation in patients with differentiated thyroid cancer – possible causes
por: Gut, Paweł, et al.
Publicado: (2012) -
The Usefulness of Standardized Uptake Value in Differentiation between Benign and Malignant Thyroid Lesions Detected Incidentally in (18)F-FDG PET/CT Examination
por: Stangierski, Adam, et al.
Publicado: (2014) -
Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatment
por: Jodłowska, Elżbieta, et al.
Publicado: (2016) -
Feasibility and efficacy of neck dissections in patients with thyroid cancer
por: Wierzbicka, Małgorzata, et al.
Publicado: (2013) -
The feasibility and efficacy of secondary neck dissections in thyroid cancer metastases
por: Wierzbicka, Malgorzata, et al.
Publicado: (2013)